Rituximab for adult primary immune thrombocytopenia

被引：2
|
作者：
Frederiksen, Henrik [1 ,2 ]
机构：
[1] Odense Univ Hosp, Dept Haematol, DK-5000 Odense, Denmark
[2] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark
来源：
LANCET HAEMATOLOGY | 2015年 / 2卷 / 02期
关键词：
DEXAMETHASONE MONOTHERAPY;
D O I：
10.1016/S2352-3026(15)00006-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E52 / E53
页数：2
相关论文
共 50 条
  • [1] Low-dose rituximab in adult patients with primary immune thrombocytopenia
    Zaja, Francesco
    Vianelli, Nicola
    Volpetti, Stefano
    Battista, Marta Lisa
    Defina, Marzia
    Palmieri, Salvatore
    Bocchia, Monica
    Medeot, Marta
    De Luca, Stefano
    Ferrara, Felicetto
    Isola, Miriam
    Baccarani, Michele
    Fanin, Renato
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (04) : 329 - 334
  • [2] SAFETY AND EFFICACY OF RITUXIMAB IN ADULT IMMUNE THROMBOCYTOPENIA
    Biagiotti, C.
    Carrai, V.
    Bacchiarri, F.
    Di Gioia, M.
    Raugei, G.
    Bosi, A.
    HAEMATOLOGICA, 2016, 101 : 831 - 831
  • [3] LOW DOSE RITUXIMAB AS SALVAGE THERAPY IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP)
    Zaja, F.
    Battista, M. L.
    Defina, M.
    Vianelli, N.
    Palmieri, S.
    Bocchia, M.
    Medeot, M.
    Volpetti, S.
    De Luca, S.
    Ferrara, F.
    Isola, M.
    Baccarani, M.
    Fanin, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 76 - 76
  • [4] SAFETY AND EFFICACY OF RITUXIMAB IN ADULT WITH CHRONIC IMMUNE THROMBOCYTOPENIA
    Biagiotti, C.
    Carrai, V.
    Bacchiarri, F.
    Alterini, R.
    Rigacci, L.
    Antonioli, E.
    Di Gioia, M.
    Raugei, G.
    Bosi, A.
    HAEMATOLOGICA, 2015, 100 : 124 - 124
  • [5] The association between antinuclear antibody and response to rituximab treatment in adult patients with primary immune thrombocytopenia
    Wang, Yan-ming
    Yu, Ya-fei
    Liu, Yu
    Liu, Shuang
    Hou, Ming
    Liu, Xin-guang
    HEMATOLOGY, 2020, 25 (01) : 139 - 144
  • [6] Cost per responder associated with romiplostim and rituximab treatment for adult primary immune thrombocytopenia in France
    Chiche, L.
    Perrin, A.
    Stern, L.
    Kutikova, L.
    Cohen-Nizard, S.
    Lefrere, F.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2014, 21 (02) : 85 - 93
  • [7] Efficacy of rituximab in primary immune thrombocytopenia: an analysis of adult pretreated patients from everyday hematological practice
    Cervinek, Libor
    Cerna, Olga
    Caniga, Miroslav
    Konirova, Eva
    Hlusi, Antonin
    Simkovic, Martin
    Pospisil, Zdenek
    Cermak, Jaroslav
    Kozak, Tomas
    Mayer, Jiri
    Doubek, Michael
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (05) : 594 - 599
  • [8] Efficacy of rituximab in primary immune thrombocytopenia: an analysis of adult pretreated patients from everyday hematological practice
    Libor Červinek
    Olga Černá
    Miroslav Čaniga
    Eva Konířová
    Antonín Hluší
    Martin Šimkovič
    Zdeněk Pospíšil
    Jaroslav Čermák
    Tomáš Kozák
    Jiří Mayer
    Michael Doubek
    International Journal of Hematology, 2012, 96 : 594 - 599
  • [9] RITUXIMAB VERSUS SPLENECTOMY IN PERSISTENT OR CHRONIC ADULT PRIMARY IMMUNE THROMBOCYTOPENIA: AN ADJUSTED COMPARISON OF MORTALITY AND MORBIDITY
    Moulis, G.
    Sailler, L.
    Sommet, A.
    Lapeyre-Mestre, M.
    Adoue, D.
    HAEMATOLOGICA, 2013, 98 : 197 - 198
  • [10] The value of platelet count in predicting the efficacy of rituximab treatment in adult patients with chronic primary immune thrombocytopenia
    王诗轩
    ChinaMedicalAbstracts(InternalMedicine), 2018, 35 (03) : 183 - 183
12345